Treatment with insulin detemir provides improved glycemic control and less weight gain compared to NPH insulin in people with diabetes

被引：0

|

作者：

Garber, AJ

Olsen, KJ

Draeger, E

机构：

来源：

DIABETES | 2004年 / 53卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A125 / A125

页数：1

相关论文

共 50 条

[41] Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin
De Leeuw, I
Vague, P
Selam, JL
Skeie, S
Lang, H
Draeger, E
Elte, JWF
[J]. DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 73 - 82
[42] Insulin Detemir Initiation Improves Glycemic Control without Weight Gain: LIGHT Study Evidence
Cokolic, Miro
Pijl, Hanno
Bozic, Petra Sencar
[J]. DIABETES, 2009, 58 : A529 - A529
[43] Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients -: The PREDICTIVE™ BMI clinical trial
Montanana, C. Fajardo
Herrero, C. Hernandez
Fernandez, M. Rivas
[J]. DIABETIC MEDICINE, 2008, 25 (08) : 916 - 923
[44] More subjects treated with insulin detemir achieve HbA1c ≤ 7% without hypoglycemia and weight gain compared to NPH insulin
Hermansen, Kjeld
Larsen, Jens
Tamer, Soren C.
Mathieu, Chantal
[J]. DIABETES, 2007, 56 : A130 - A130
[45] Metformin Treatment of Gestational Diabetes Results in Similar Glycemic Control and Infant Outcomes but Less Maternal Weight Gain Than Insulin Treatment
McLean, Mark
Lau, Sue Lynn
Pereira, Lorraine
Hendon, Susan
Bradford, Jennifer
Hng, Tien-Ming
[J]. ENDOCRINE REVIEWS, 2014, 35 (03)
[46] Once daily dosing with insulin detemir offers advantages compared to NPH insulin in subjects with type 1 diabetes
Russel-Jones, D
Bolinder, J
Simpson, R
Stades, A
Stender, A
Hylleberg, B
Draeger, E
[J]. DIABETES, 2003, 52 : A132 - A132
[47] Feasibility of improved glycemic control with insulin detemir and insulin glargine in combination with oral agents in insulin naive patients with type 2 diabetes
Rosenstock, J
Larsen, JJ
Draeger, E
Kristensen, HS
Davies, M
[J]. DIABETES, 2004, 53 : A145 - A145
[48] Use of insulin deternir once-daily results in less weight gain compared with the use of NPH insulin, particularly in obese subjects with type 2 diabetes
Philis-Tsimikas, A.
Koenen, C.
Pedersen, C. B.
Thorsteinsson, B.
[J]. DIABETOLOGIA, 2007, 50 : S404 - S404
[49] Subcutaneous insulin detemir compared with NPH insulin increases brain potential responses with similar systemic metabolic effects in people with Type 1 diabetes
Herring, R.
Shojaee-Moradie, F.
Umpleby, M.
Jackson, N.
Jones, R.
Derk-Jan, D.
Knight, R.
Russell-Jones, D.
[J]. DIABETIC MEDICINE, 2014, 31 : 62 - 62
[50] Insulin glulisine provides improved glycemic control in patients with type 2 diabetes
Dailey, G
Rosenstock, J
Moses, RG
Ways, K
[J]. DIABETES CARE, 2004, 27 (10) : 2363 - 2368

← 1 2 3 4 5 →